Patents by Inventor Per Holse Mygind

Per Holse Mygind has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100104552
    Abstract: The present invention relates to antibiotic synergism of pharmaceutical compositions comprising a defensin and a beta-lactam antibiotic.
    Type: Application
    Filed: October 23, 2009
    Publication date: April 29, 2010
    Applicant: Novozymes A/S
    Inventors: Per Holse Mygind, Dorthe Sandvang, Hans-Henrik Kristensen Hoegenhaug, Thomas Kruse, Line Anker Nielsen
  • Patent number: 7671175
    Abstract: The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: June 5, 2006
    Date of Patent: March 2, 2010
    Assignee: Novozymes Adenium Biotech A/S
    Inventors: Jesper Vind, Dorotea Raventos Segura, Hans-Henrik Kristensen Hoegenhaug, Per Holse Mygind, Olivier Taboureau
  • Publication number: 20100016230
    Abstract: The present invention relates to treatment of inflammatory bowel diseases with mammal beta defensins.
    Type: Application
    Filed: July 17, 2009
    Publication date: January 21, 2010
    Applicant: Novozymes A/S
    Inventors: Tanja Maria Rosenkilde Kjaer, Thomas Kruse, Per Holse Mygind, Karoline Sidelmann Brinch, Soeren Kjaerulff, Birgitte Andersen
  • Publication number: 20100016231
    Abstract: The present invention relates to treatment of rheumatoid arthritis with mammal beta defensins.
    Type: Application
    Filed: July 17, 2009
    Publication date: January 21, 2010
    Applicant: Novozymes A/S
    Inventors: Tanja Maria Rosenkilde Kjaer, Thomas Kruse, Per Holse Mygind, Karoline Sidelmann Brinch, Soeren Kjaerulff, Birgitte Andersen
  • Publication number: 20100016232
    Abstract: The present invention relates to suppression of TNF-alpha activity with mammal beta defensins, which has utility in the treatment of pathological conditions associated with tumor necrosis factor alpha.
    Type: Application
    Filed: July 17, 2009
    Publication date: January 21, 2010
    Applicant: Novozymes A/S
    Inventors: Tanja Maria Rosenkilde Kjaer, Thomas Kruse, Per Holse Mygind, Karoline Sidelmann Brinch, Soeren Kjaerulff, Birgitte Andersen
  • Publication number: 20090137481
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: January 19, 2009
    Publication date: May 28, 2009
    Applicant: Novozymes A/S
    Inventors: Hans-Henrik Kristensen Hogenhaug, Per Holse Mygind, Dorotea Raventos Segura, Olivier Taboureau, Carsten Peter Sonksen
  • Patent number: 7504375
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: August 22, 2006
    Date of Patent: March 17, 2009
    Assignee: Novozymes A/S
    Inventors: Hans-Henrik Kristensen Hogenhaug, Per Holse Mygind, Dorotea Raventos Segura, Olivier Taboureau, Carsten Peter Sonksen
  • Publication number: 20080213430
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: June 10, 2004
    Publication date: September 4, 2008
    Applicants: Novozymes A/S, Universita' Degli Studi Di Trieste Dipartimento di Biochimica
    Inventors: Dorotea Raventos Segura, Per Holse Mygind, Hans-Henrik Kristensen Hoegenhaug, Alessandro Tossi
  • Patent number: 7388077
    Abstract: The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: November 11, 2005
    Date of Patent: June 17, 2008
    Assignee: Novozymes A/S
    Inventors: Per Holse Mygind, Mogens Trier Hansen, Marianne Vind Soerensen, Dorthe Sandvang
  • Patent number: 7148404
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: May 2, 2005
    Date of Patent: December 12, 2006
    Assignee: Novozymes A/S
    Inventors: Hans-Henrik Kristensen Hogenhaug, Per Holse Mygind, Dorotea Raventos Segura, Olivier Taboureau, Carsten Peter Sonksen